Science DailyClear view on stem cell developmentScience DailyWhen stem cells develop into specialized cells, this happens in multiple steps. But which regulatory proteins are active during the decisive branching on the development path? Using so-called… Continue reading
Phys.OrgClear view on stem cell developmentPhys.OrgWhen stem cells develop into specialized cells, this happens in multiple steps. But which regulatory proteins are active during the decisive branching on the development path? Using so-called time-laps… Continue reading
Phys.OrgClear view on stem cell developmentPhys.OrgWhen stem cells develop into specialized cells, this happens in multiple steps. But which regulatory proteins are active during the decisive branching on the development path? Using so-called time-laps… Continue reading
The Epoch TimesConsumers Remain in the Dark About Potential Risks of New GMO TechniquesThe Epoch TimesAgrochemical giant Monsanto announced in January that it will be using Crispr-Cas9 and its sister technology, Crispr-Cpf1, to create new crops. Cibus,… Continue reading
The Epoch TimesConsumers Remain in the Dark About Potential Risks of New GMO TechniquesThe Epoch TimesAgrochemical giant Monsanto announced in January that it will be using Crispr-Cas9 and its sister technology, Crispr-Cpf1, to create new crops. Cibus,… Continue reading
The Epoch TimesConsumers Remain in the Dark About Potential Risks of New GMO TechniquesThe Epoch TimesAgrochemical giant Monsanto announced in January that it will be using Crispr-Cas9 and its sister technology, Crispr-Cpf1, to create new crops. Cibus,… Continue reading
FierceBiotech |
Sarepta signs another Duchenne gene therapy pact as it aims for wider treatment
FierceBiotech Sarepta Therapeutics has penned its second DMD gene therapy pact this year as it announces a tie-up with France’s Genethon, a nonprofit R&D org. The research collaboration will see the Franco-American pair jointly develop treatments for Duchenne … Sarepta Therapeutics and Genethon Announce a Gene Therapy Research Collaboration for the Treatment of …Nasdaq |
|
Journal alerts readers to “technical criticism” of CRISPR study
Retraction Watch (blog) A Nature journal has posted a editor’s note to a recent letter on potential unintended consequences of CRISPR gene editing, after an executive at a company trying to commercialize the technology said the paper should be retracted. The original article … |